![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 39/00 | (2006.01) | ||
A61K 47/68 | (2017.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 15/00 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3221355 |
(13) | Kind of document | T |
(96) | European patent application number | 15797954.3 |
Date of filing the European patent application | 2015-11-16 | |
(97) | Date of publication of the European application | 2017-09-27 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
(46) | Date of publication of the claims translation | 2020-12-28 |
(86) | Number | PCT/EP2015/076682 |
Date | 2015-11-16 |
(87) | Number | WO 2016/079050 |
Date | 2016-05-26 |
(30) | Number | Date | Country code |
14194136 | 2014-11-20 | EP | |
15152141 | 2015-01-22 | EP | |
15167173 | 2015-05-11 | EP |
(72) |
KLEIN, Christian, CH
KARANIKAS, Vaios, CH
UMANA, Pablo, CH
ZIPPELIUS, Alfred, CH
THOMMEN, Daniela, CH
SCHREINER, Jens, CH
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kombinuotoji T ląsteles aktyvinančių bispecifinių antigeną surišančių molekulių CD3 bei folato receptoriaus 1 (FOLR1) ir PD-1 ašį surišančių antagonistų terapija |
COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES CD3 AND FOLATE RECEPTOR 1 (FOLR1) AND PD-1 AXIS BINDING ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2024-10-22 | 10 | 231.00 EUR |
2025-11-16 |